Operative Hysteroscopy vs Vacuum Aspiration for Incomplete Spontaneous Abortion: A Randomized Clinical Trial.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
11 04 2023
Historique:
medline: 13 4 2023
entrez: 11 4 2023
pubmed: 12 4 2023
Statut: ppublish

Résumé

Vacuum aspiration is commonly used to remove retained products of conception in patients with incomplete spontaneous abortion. Scarring of the uterine cavity may occur, potentially impairing future fertility. A procedural alternative, operative hysteroscopy, has gained popularity with a presumption of better future fertility. To assess the superiority of hysteroscopy to vacuum aspiration for subsequent pregnancy in patients with incomplete spontaneous abortion who intend to have future pregnancy. The HY-PER randomized, controlled, single-blind trial included 574 patients between November 6, 2014, and May 3, 2017, with a 2-year duration of follow-up. This multicenter trial recruited patients in 15 French hospitals. Individuals aged 18 to 44 years and planned for surgery for an incomplete spontaneous abortion with plans to subsequently conceive were randomized in a 1:1 ratio. Surgical treatment by hysteroscopy (n = 288) or vacuum aspiration (n = 286). The primary outcome was a pregnancy of at least 22 weeks' duration during 2-year follow-up. The intention-to-treat analyses included 563 women (mean [SD] age, 32.6 [5.4] years). All aspiration procedures were completed. The hysteroscopic procedure could not be completed for 19 patients (7%), 18 of which were converted to vacuum aspiration (8 with inability to completely resect, 7 with insufficient visualization, 2 with anesthetic complications that required a shortened procedure, 1 with equipment failure). One hysteroscopy failed due to a false passage during cervical dilatation. During the 2-year follow-up, 177 patients (62.8%) in the hysteroscopy group and 190 (67.6%) in the vacuum aspiration (control) group achieved the primary outcome (difference, -4.8% [95% CI, -13% to 3.0%]; P = .23). The time-to-event analyses showed no statistically significant difference between groups for the primary outcome (hazard ratio, 0.87 [95% CI, 0.71 to 1.07]). Duration of surgery and hospitalization were significantly longer for hysteroscopy. Rates of new miscarriages, ectopic pregnancies, Clavien-Dindo surgical complications of grade 3 or above (requiring surgical, endoscopic, or radiological intervention or life-threatening event or death), and reinterventions to remove remaining products of conception did not differ between groups. Surgical management by hysteroscopy of incomplete spontaneous abortions in patients intending to conceive again was not associated with more subsequent births or a better safety profile than vacuum aspiration. Moreover, operative hysteroscopy was not feasible in all cases. ClinicalTrials.gov Identifier: NCT02201732.

Identifiants

pubmed: 37039805
pii: 2803517
doi: 10.1001/jama.2023.3415
pmc: PMC10091175
doi:

Banques de données

ClinicalTrials.gov
['NCT02201732']

Types de publication

Journal Article Research Support, Non-U.S. Gov't Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

1197-1205

Commentaires et corrections

Type : CommentOn
Type : ErratumIn

Références

Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):116-20
pubmed: 19203825
BMJ. 2009 Oct 08;339:b3827
pubmed: 19815581
Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:98-102
pubmed: 28214435
Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:19-22
pubmed: 24332096
Biometrics. 1978 Sep;34(3):483-6
pubmed: 719125
Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:18-26
pubmed: 27039249
BMJ. 1998 Dec 5;317(7172):1572
pubmed: 9836663
Cochrane Database Syst Rev. 2021 Jun 1;6:CD012602
pubmed: 34061352
Fertil Steril. 2016 Jan;105(1):156-64.e1-2
pubmed: 26453977
Obstet Gynecol. 2020 Nov;136(5):912-921
pubmed: 33030878
Int J Gynaecol Obstet. 2014 Oct;127(1):86-9
pubmed: 24997472
Dialogues Clin Neurosci. 2011;13(2):217-24
pubmed: 21842619
J Minim Invasive Gynecol. 2009 Jul-Aug;16(4):487-90
pubmed: 19573826
N Engl J Med. 2018 Nov 15;379(20):1895-1904
pubmed: 30380365
Fertil Steril. 2017 May;107(5):1223-1231.e3
pubmed: 28390688
Lancet. 2002 Feb 23;359(9307):696-700
pubmed: 11879884
J Am Assoc Gynecol Laparosc. 2001 May;8(2):199-202
pubmed: 11342724
J Minim Invasive Gynecol. 2011 Nov-Dec;18(6):774-8
pubmed: 22024264
BMJ. 2001 Jun 2;322(7298):1343-6
pubmed: 11387184
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
BMJ. 2019 Nov 13;367:l6283
pubmed: 31722871
J Minim Invasive Gynecol. 2021 Feb;28(2):204-217
pubmed: 33166659
J Minim Invasive Gynecol. 2011 Jan-Feb;18(1):100-3
pubmed: 21195960
Lancet. 2021 May 1;397(10285):1658-1667
pubmed: 33915094
Trials. 2015 Aug 19;16:363
pubmed: 26282937

Auteurs

Cyrille Huchon (C)

Department of Gynecology and Obstetrics, APHP, Hopital Lariboisière, University of Paris Cité, Paris, France.
Université Paris-Saclay, UVSQ, Unité de Recherche 7285, Risques Cliniques et Sécurité en Santé des Femmes et en Santé Périnatale (RISCQ), Montigny-le-Bretonneux, France.
Department of Gynecology and Obstetrics, CHI Poissy-St-Germain, Poissy CEDEX, France.

Hocine Drioueche (H)

Department of Clinical Research, Centre Hospitalier Intercommunal de Poissy-Saint-Germain-en-Laye, Poissy, France.

Martin Koskas (M)

Université Paris-Saclay, UVSQ, Unité de Recherche 7285, Risques Cliniques et Sécurité en Santé des Femmes et en Santé Périnatale (RISCQ), Montigny-le-Bretonneux, France.
Department of Gynecology and Obstetrics, APHP, Hôpital Bichat, Paris, France.

Aubert Agostini (A)

Department of Gynecology and Obstetrics, Hôpital La Conception, Marseille CEDEX 5, France.

Estelle Bauville (E)

Department of Gynecology and Obstetrics, Rennes University Hospital, Rennes CEDEX 2, France.

Nicolas Bourdel (N)

Department of Gynecologic Surgery, CHU Estaing Clermont Ferrand, 63058 Clermont Ferrand CEDEX 1, Faculty of Medicine, ISIT - Université d'Auvergne, Clermont-Ferrand, France.

Hervé Fernandez (H)

Department of Gynecology and Obstetrics, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre, 94270, France.
Centre for Epidemiology and Population Health-INSERM U1018, Université Paris Sud, Le Kremlin Bicêtre, France.

Xavier Fritel (X)

Department of Gynecology and Obstetrics, CHU de Poitiers, Université de Poitiers, Faculté de Médecine et Pharmacie, Inserm CIC1402, Poitiers, France.

Olivier Graesslin (O)

Department of Gynecology and Obstetrics, Hôpital Alix de Champagne, CHU de Reims, Reims, France.

Guillaume Legendre (G)

Department of Gynecology and Obstetrics, CHU d'Angers, Angers CEDEX 01, France.

Jean-Philippe Lucot (JP)

Department of Gynecology and Obstetrics, Hôpital Jeanne-de-Flandre, CHRU de Lille, Lille, France.

Pierre Panel (P)

Department of Gynecology and Obstetrics, Centre Hospitalier de Versailles, Le Chesnay, France.

Cyril Raiffort (C)

Department of Gynecology and Obstetrics, APHP, Hôpital Louis Mourier, Département Hospitalier Universitaire Risque et Grossesse, Colombes, University of Paris Cité, Paris, France.

Géraldine Giraudet (G)

Department of Gynecology and Obstetrics, Hôpital Jeanne-de-Flandre, CHRU de Lille, Lille, France.

Laurence Bussières (L)

Clinical Unit Research/Clinic Investigation Center, Paris Descartes, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.

Arnaud Fauconnier (A)

Université Paris-Saclay, UVSQ, Unité de Recherche 7285, Risques Cliniques et Sécurité en Santé des Femmes et en Santé Périnatale (RISCQ), Montigny-le-Bretonneux, France.
Department of Gynecology and Obstetrics, CHI Poissy-St-Germain, Poissy CEDEX, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH